Investigation of the effect of a combination of specific amino acids oral supplements in patients with diabetic nephropathy: a randomized controlled phase 1 clinical trial

Esfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年11月1日

试验速览

暂无简介。

•Age 18 years or older
•men or non-pregnant and non-lactating women with type 1 or type II diabetes and kidney disease
•Participants with albumin in urine: Diabetic patients whose albumin level is 30-300 mg / 24h is used for this study (stage 3 of the stages of diabetic nephropathy)
•Willingness and ability to consciously consent and cooperate with the protocol, including discontinuation of current hypertension medications if necessary

•Pregnant or lactating women
•People with inflammatory or chronic autoimmune diseases
•People with chronic kidney disease for reasons other than diabetes
•People with organ transplants
•People with blood pressure 16 over 9 and above
•People with hepatitis B or C viral liver infection, liver cirrhosis or significant liver disease
•People with recent gastrointestinal bleeding
•People with acute kidney damage in the 3 months before screening
•Individuals who have undergone major surgery within 3 months prior to screening or plan to have it during the study period.
•People with HIV infection with the virus that causes AIDS.
•People with heart disease that is not considered stable.
•People with active cancer or another disease that greatly increases the risk of cancer.
•People with the need to take drugs that alter the immune system.
•The patient's do not follow a diet with limited protein.

发起方